190 related articles for article (PubMed ID: 30059018)
1. SUMO-defective c-Maf preferentially transactivates Il21 to exacerbate autoimmune diabetes.
Hsu CY; Yeh LT; Fu SH; Chien MW; Liu YW; Miaw SC; Chang DM; Sytwu HK
J Clin Invest; 2018 Aug; 128(9):3779-3793. PubMed ID: 30059018
[TBL] [Abstract][Full Text] [Related]
2. SUMO conjugation contributes to immune deviation in nonobese diabetic mice by suppressing c-Maf transactivation of IL-4.
Leavenworth JW; Ma X; Mo YY; Pauza ME
J Immunol; 2009 Jul; 183(2):1110-9. PubMed ID: 19553542
[TBL] [Abstract][Full Text] [Related]
3. c-Maf activates the promoter and enhancer of the IL-21 gene, and TGF-beta inhibits c-Maf-induced IL-21 production in CD4+ T cells.
Hiramatsu Y; Suto A; Kashiwakuma D; Kanari H; Kagami S; Ikeda K; Hirose K; Watanabe N; Grusby MJ; Iwamoto I; Nakajima H
J Leukoc Biol; 2010 Apr; 87(4):703-12. PubMed ID: 20042469
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-21-producing c-Maf-expressing CD4+ T cells induce effector CD8+ T cells and enhance autoimmune inflammation in scurfy mice.
Iwamoto T; Suto A; Tanaka S; Takatori H; Suzuki K; Iwamoto I; Nakajima H
Arthritis Rheumatol; 2014 Aug; 66(8):2079-90. PubMed ID: 24719360
[TBL] [Abstract][Full Text] [Related]
5. IL-6 plays a unique role in initiating c-Maf expression during early stage of CD4 T cell activation.
Yang Y; Ochando J; Yopp A; Bromberg JS; Ding Y
J Immunol; 2005 Mar; 174(5):2720-9. PubMed ID: 15728480
[TBL] [Abstract][Full Text] [Related]
6. c-Maf interacts with c-Myb to down-regulate Bcl-2 expression and increase apoptosis in peripheral CD4 cells.
Peng S; Lalani S; Leavenworth JW; Ho IC; Pauza ME
Eur J Immunol; 2007 Oct; 37(10):2868-80. PubMed ID: 17823980
[TBL] [Abstract][Full Text] [Related]
7. Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions.
Graser RT; DiLorenzo TP; Wang F; Christianson GJ; Chapman HD; Roopenian DC; Nathenson SG; Serreze DV
J Immunol; 2000 Apr; 164(7):3913-8. PubMed ID: 10725754
[TBL] [Abstract][Full Text] [Related]
8. Variable effects of transgenic c-Maf on autoimmune diabetes.
Pauza ME; Nguyen A; Wolfe T; Ho IC; Glimcher LH; von Herrath M; Lo D
Diabetes; 2001 Jan; 50(1):39-46. PubMed ID: 11147792
[TBL] [Abstract][Full Text] [Related]
9. Impaired IL-4 production by CD8+ T cells in NOD mice is related to a defect of c-Maf binding to the IL-4 promoter.
Chen XP; Falkner DH; Morel PA
Eur J Immunol; 2005 May; 35(5):1408-17. PubMed ID: 15832295
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine phosphorylation of c-Maf enhances the expression of IL-4 gene.
Lai CY; Lin SY; Wu CK; Yeh LT; Sytwu HK; Miaw SC
J Immunol; 2012 Aug; 189(4):1545-50. PubMed ID: 22798672
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of Nuclear Factor-κB c-Rel Accelerates the Development of Autoimmune Diabetes in NOD Mice.
Ramakrishnan P; Yui MA; Tomalka JA; Majumdar D; Parameswaran R; Baltimore D
Diabetes; 2016 Aug; 65(8):2367-79. PubMed ID: 27217485
[TBL] [Abstract][Full Text] [Related]
12. SUMOylation attenuates c-Maf-dependent IL-4 expression.
Lin BS; Tsai PY; Hsieh WY; Tsao HW; Liu MW; Grenningloh R; Wang LF; Ho IC; Miaw SC
Eur J Immunol; 2010 Apr; 40(4):1174-84. PubMed ID: 20127678
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic remodeling of the IL-2 and IFN-gamma loci in memory CD8 T cells is influenced by CD4 T cells.
Northrop JK; Thomas RM; Wells AD; Shen H
J Immunol; 2006 Jul; 177(2):1062-9. PubMed ID: 16818762
[TBL] [Abstract][Full Text] [Related]
14. IL-10 impacts autoimmune diabetes via a CD8+ T cell pathway circumventing the requirement for CD4+ T and B lymphocytes.
Balasa B; Davies JD; Lee J; Good A; Yeung BT; Sarvetnick N
J Immunol; 1998 Oct; 161(8):4420-7. PubMed ID: 9780221
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the regulatory roles of the SUMO.
Hwang KW; Won TJ; Kim H; Chun HJ; Chun T; Park Y
Diabetes Metab Res Rev; 2011 Nov; 27(8):854-61. PubMed ID: 22069273
[TBL] [Abstract][Full Text] [Related]
16. Erratum to ‘‘Characterization of the regulatory roles of the SUMO.
Hwang KW; Won TJ; Kim H; Chun HJ; Chun T; Park Y
Diabetes Metab Res Rev; 2012 Feb; 28(2):196-202. PubMed ID: 22423385
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-21-dependent modulation of T cell antigen receptor reactivity towards low affinity peptide ligands in autoreactive CD8(+) T lymphocytes.
Bobbala D; Orkhis S; Kandhi R; Ramanathan S; Ilangumaran S
Cytokine; 2016 Sep; 85():83-91. PubMed ID: 27300756
[TBL] [Abstract][Full Text] [Related]
18. CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses.
Hammitzsch A; Tallant C; Fedorov O; O'Mahony A; Brennan PE; Hay DA; Martinez FO; Al-Mossawi MH; de Wit J; Vecellio M; Wells C; Wordsworth P; Müller S; Knapp S; Bowness P
Proc Natl Acad Sci U S A; 2015 Aug; 112(34):10768-73. PubMed ID: 26261308
[TBL] [Abstract][Full Text] [Related]
19. Development of memory-like autoregulatory CD8+ T cells is CD4+ T cell dependent.
Shameli A; Clemente-Casares X; Wang J; Santamaria P
J Immunol; 2011 Sep; 187(6):2859-66. PubMed ID: 21824864
[TBL] [Abstract][Full Text] [Related]
20. alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10.
Hammond KJ; Poulton LD; Palmisano LJ; Silveira PA; Godfrey DI; Baxter AG
J Exp Med; 1998 Apr; 187(7):1047-56. PubMed ID: 9529321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
